Luminespib mesylate

Luminespib (AUY-922) is a potent, third-generation Hsp90 inhibitor that induces the degradation of oncogenic client proteins, leading to anti-proliferative effects in tumor cells. It has demonstrated activity in preclinical in vitro and in vivo studies across various cancer research fields, including solid tumors and hematological malignancies.